Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
T. Rowe Price Growth Stock ETF | TGRW | Apr 26, 2024 | 33.46 | +1.90 |
T2 Biosystems | TTOO | Apr 26, 2024 | 2.84 | +3.65 |
Taboola.com | TBLA | Apr 26, 2024 | 4.23 | +0.71 |
Tactile Systems Technology | TCMD | Apr 26, 2024 | 14.30 | +0.21 |
Taitron Components A | TAIT | Apr 26, 2024 | 3.17 | +0.32 |
Taiwan Fund | TWN | Apr 26, 2024 | 38.36 | +1.67 |
Taiwan Index MSCI Ishares | EWT | Apr 26, 2024 | 47.10 | +1.20 |
Taiwan Semiconductor Manufacturing ADR | TSM | Apr 26, 2024 | 138.30 | +1.26 |
Take-Two Interactive Software | TTWO | Apr 26, 2024 | 144.47 | +0.73 |
Takeda Pharmaceutical ADR | TAK | Apr 26, 2024 | 13.03 | -0.31 |
TAL Education Group ADR | TAL | Apr 26, 2024 | 13.41 | +0.45 |
Talis Biomedical | TLIS | Apr 26, 2024 | 9.14 | +1.56 |
Talkspace | TALK | Apr 26, 2024 | 3.12 | +1.30 |
Talos Energy | TALO | Apr 26, 2024 | 13.94 | +1.16 |
Talphera | TLPH | Apr 26, 2024 | 1.05 | 0.00 |
Tandem Diabetes Care | TNDM | Apr 26, 2024 | 35.24 | -0.90 |
Tanger | SKT | Apr 26, 2024 | 28.88 | +0.73 |
Tango Therapeutics | TNGX | Apr 26, 2024 | 7.44 | +1.50 |
Tantech | TANH | Apr 26, 2024 | 0.56 | 0.00 |
Taoping | TAOP | Apr 26, 2024 | 0.98 | -5.77 |
Tapestry | TPR | Apr 26, 2024 | 40.05 | +1.68 |
Targa Resources | TRGP | Apr 26, 2024 | 116.86 | -0.70 |
Target | TGT | Apr 26, 2024 | 164.74 | +0.18 |
Target Global Acquisition I A | TGAA | Apr 26, 2024 | 11.20 | 0.00 |
Target Global Acquisition I Unit | TGAAU | Apr 26, 2024 | 11.13 | 0.00 |
Target Hospitality | TH | Apr 26, 2024 | 11.12 | +0.36 |
Taro Pharmaceutical Industries | TARO | Apr 26, 2024 | 42.40 | -0.19 |
Tarsus Pharmaceuticals | TARS | Apr 26, 2024 | 32.04 | -0.53 |
Taseko Mines | TGB | Apr 26, 2024 | 2.60 | +5.26 |
TaskUs A | TASK | Apr 26, 2024 | 11.59 | +2.57 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.